Brief: Moody's Ratings Assigns Baa1 Long-Term Issuer Rating To Sun Pharmaceutical Industries
BRIEF-Moody's Ratings Assigns Baa1 Long-Term Issuer Rating To Sun Pharmaceutical Industries Sept 8 (Reuters) -
MOODY'S RATINGS: ASSIGNED BAA1 LONG-TERM ISSUER RATING TO SUN PHARMACEUTICAL INDUSTRIES
Source text: ID:nMDY8h8KMs
Further company coverage: SUN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses